Hannah Goulart

13PUBLICATIONS
44CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 27, 2026
Inotuzumab ozogamicin therapy for measurable residual disease in adult acute lymphoblastic leukemia.

|Dec 10, 2025
Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia.

Hannah Goulart, Farhad Ravandi, Nicholas J Short

|May 09, 2025
Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangements.

Alex Bataller, Hannah E Goulart, Ghayas C Issa

|Apr 07, 2025
Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single-center, single-arm, phase 2 trial.

Hannah Goulart, Hagop Kantarjian, Gautam Borthakur

|Feb 17, 2025
Maintenance Therapy in AML: What Is the Future Potential?

Hannah Goulart, Andrew H Wei, Tapan M Kadia

|Nov 20, 2024
Venetoclax-Based Combination Regimens in Acute Myeloid Leukemia.

Hannah Goulart, Hagop Kantarjian, Naveen Pemmaraju

Pageof 3

Frequent Collaborators

8 joint publications

Tapan M Kadia

7 joint publications

Farhad Ravandi

6 joint publications

Caitlin Rausch

6 joint publications

Courtney DiNardo